Indication
Mixed hyperlipidemia
Mixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems. Read more about Mixed hyperlipidemia
284 drugs 119 manufacturers
Drugs that treat it
Common Mixed hyperlipidemia therapies.
EZETIMIBE
EZETIMIBE-SIMVASTATIN (ezetimibe/simvastatin)
LOVASTATIN
PRAVASTATIN SODIUM
ROSUVASTATIN CALCIUM
SIMVASTATIN
ATORVASTATIN CALCIUM
EZETIMIBE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems.
It is defined by the concurrent elevation of both serum cholesterol, primarily carried on low-density lipoprotein (LDL), and triglycerides, typically enriched in very-low-density lipoproteins (VLDL) and remnant lipoproteins.
This atherogenic profile frequently presents with decreased high-density lipoprotein cholesterol (HDL-C) and an increased concentration of apolipoprotein B-containing particles.
It can arise as a primary genetic condition, such as familial combined hyperlipidemia, or secondary to metabolic derangements including obesity, insulin resistance, type 2 diabetes mellitus, and nephrotic syndrome.
- nih.gov
Mixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems It is defined by the concurrent elevation of both serum cholesterol, primarily carried on low-density lipoprotein (LDL), and triglycerides, typically enriched in very-low-density lipoproteins (VLDL) and remnant lipoproteins It can arise as a primary genetic condition, such as familial combined hyperlipidemia, or secondary to metabolic derangements incl...
- nih.gov
Mixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems
- nih.gov
It is defined by the concurrent elevation of both serum cholesterol, primarily carried on low-density lipoprotein (LDL), and triglycerides, typically enriched in very-low-density lipoproteins (VLDL) and remnant lipoproteins It can arise as a primary genetic condition, such as familial combined hyperlipidemia, or secondary to metabolic derangements including obesity, insulin resistance, type 2 diabetes mellitus, and nephrotic syndrome
- icfamilymedicine.com
It is defined by the concurrent elevation of both serum cholesterol, primarily carried on low-density lipoprotein (LDL), and triglycerides, typically enriched in very-low-density lipoproteins (VLDL) and remnant lipoproteins
- nih.gov
This atherogenic profile frequently presents with decreased high-density lipoprotein cholesterol (HDL-C) and an increased concentration of apolipoprotein B-containing particles
- substack.com
This atherogenic profile frequently presents with decreased high-density lipoprotein cholesterol (HDL-C) and an increased concentration of apolipoprotein B-containing particles
- mdedge.com
It can arise as a primary genetic condition, such as familial combined hyperlipidemia, or secondary to metabolic derangements including obesity, insulin resistance, type 2 diabetes mellitus, and nephrotic syndrome
Personalize your experience
Follow Mixed hyperlipidemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.